Media for clostridium bacterium and processes for obtaining a clostridial toxin

Details for Australian Patent Application No. 2005327457 (hide)

Owner Allergan, Inc.

Inventors Wang, Ping; Donovan, Stephen

Agent Davies Collison Cave

Pub. Number AU-B-2005327457

PCT Pub. Number WO2006/096164

Priority 11/072,050 03.03.05 US; 11/072,673 03.03.05 US

Filing date 3 March 2005

Wipo publication date 5 October 2006

Acceptance publication date 23 August 2012

International Classifications

C07K 14/33 Peptides having more than 20 amino acids

C12N 1/20 Micro-organisms, e.g. protozoa - Bacteria

Event Publications

5 October 2006 Application Open to Public Inspection

  Published as AU-B-2005327457

5 October 2006 PCT application entered the National Phase

  PCT publication WO2006/096164 Priority application(s): WO2006/096164

18 December 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Name Allergan, Inc., Application No. 2005327457, under INID (43) correct the date to 14 September 2006

23 August 2012 Application Accepted

  Published as AU-B-2005327457

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005327458-Animal product free system and process for purifying a botulinum toxin

2005327456-Waterslide